Aetion

By Dave Muoio 11:35 am August 26, 2020
Real-world evidence (RWE) technology startup Aetion has extended last year's $63 million Series B with a new $19 million raise. The funds come as strategic investments from Johnson & Johnson Innovation, JJDC, EDBI and Greenspring Associates, all three of which are new supporters of the company. WHAT IT DOES Founded in 2013, the company's platform provides insights from RWE to decision-makers...
By Dave Muoio 02:54 pm April 22, 2020
Real-world evidence platforms Aetion and HealthVerity are playing to their strengths with the joint launch of new tools to support biopharmas and regulators gauging new COVID-19 treatments. The first, called the Real-Time Evidence Platform, is built on an instance of Aetion's platform and focuses on up-to-date usage, safety and effectiveness data. The Real-Time Trend Reporting and Interactive...
By Dave Muoio 03:50 pm February 17, 2020
Digital diabetes management company Glooko has announced the appointments of a new CCO and COO. The first role went to Zach Henderson, formerly of LexisNexis Health Care and Elsevier, he will be in charge of key strategic partners and revenue generation for Glooko. “As the leader in diabetes data management, Glooko is integrated with more diabetes and health devices than any other platform in the...
By Dave Muoio 04:37 pm December 4, 2019
Dr. John Halamka, a longtime CIO, executive director and professor tied to Harvard-affiliated Beth Israel Deaconness Medical Center, will be joining the Mayo Clinic on January 1 as the new president of its Mayo Clinic Platform — a digital health project that will deploy “artificial intelligence, the internet of things and an ecosystem of partners,” he wrote in a blog post announcing the move....
By Dave Muoio 03:12 pm November 20, 2019
Sanofi is merging its real-world data platform with New York startup Aetion’s similar evidence platform to augment its treatment development and deployment efforts, the companies announced today. Sanofi’s DARWIN platform will provide a substantial body of de-identified patient data, which the Aetion Evidence Platform will analyze those information for insights on drug effectiveness, safety and...
By Dave Muoio 11:23 am February 5, 2019
New York City-based Aetion, which makes an analytics platform to assess real-world evidence from a range of sources, has raised $27 million in a funding round supported by new backers Sanofi, UCB, McKesson Ventures and Horizon Health Services, according to a release. Prior investors including NEA, Flare Capital and Lakestar also participated. An add-on to prior funding from last year, today’s...
By Heather Mack 04:08 pm March 20, 2017
New York-based healthcare technology company, Aetion, which makes an analytics platform to assess real-world evidence from a range of sources, has raised $11.2 million in Series A funding. Flare Capital Partners, a VC firm focused on early stage health technology and services, led the round, and Lakestar also contributed. Aetion’s Evidence Platform, which the company launched in 2015, allows...